新型生物疗法在糖尿病足溃疡治疗中的研究进展
Research Progress of Novel Biological Therapies in the Treatment of Diabetic Foot Ulcers
DOI: 10.12677/acm.2024.14112938, PDF,    科研立项经费支持
作者: 高金金, 孙 甫*:西安医学院研究生院,西安;西安医学院第一附属医院骨科,西安;杨玉林, 郭文博:西安医学院研究生院,西安
关键词: 糖尿病足溃疡生长因子外泌体生物组织工程Diabetic Foot Ulcer Growth Factors Exosomes Biological Tissue Engineering
摘要: 糖尿病足溃疡是长病程糖尿病患者中最常见且最棘手的并发症,比正常伤口更难愈合,容易恶化,严重者可导致截肢。DFU的愈合机制目前尚不清晰,高糖环境、血管病变、神经病变、微生物感染、异常炎症反应等综合因素共同促成糖尿病创面。各种细胞因子的应用、外泌体中的生物分子、基质金属蛋白酶及其抑制剂、外科应用胫骨横向骨搬移术及新型生物组织工程技术等为DFU的愈合提供了新的方向。本文献将新型生物疗法在DFU治疗上的进展、不足及期望做出了总结,以望生物疗法成为未来治疗DFU的新策略。
Abstract: Diabetic foot ulcer is the most common and troublesome complication in diabetic patients with a long course. It is more difficult to heal and easy to deteriorate than normal wounds, and can lead to amputation in severe cases. The healing mechanism of DFU is still unclear, and the comprehensive factors such as high glucose environment, vascular lesions, neuropathy, microbial infection, and abnormal inflammatory response jointly contribute to the diabetic wound. The application of various cell factors, biological molecules in exosomes, MMP and their inhibitors, surgical applications of TTT, and new Biological tissue engineering techniques provide a new direction for the healing of DFU. This literature summarizes the progress, deficiencies and expectations of new biological therapy in DFU treatment, and hopes that biological therapy will become a new strategy for treating DFU in the future.
文章引用:高金金, 杨玉林, 郭文博, 孙甫. 新型生物疗法在糖尿病足溃疡治疗中的研究进展[J]. 临床医学进展, 2024, 14(11): 727-733. https://doi.org/10.12677/acm.2024.14112938

参考文献

[1] Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article 107843. [Google Scholar] [CrossRef] [PubMed]
[2] Chang, M. and Nguyen, T.T. (2021) Strategy for Treatment of Infected Diabetic Foot Ulcers. Accounts of Chemical Research, 54, 1080-1093. [Google Scholar] [CrossRef] [PubMed]
[3] Bowling, F.L., Rashid, S.T. and Boulton, A.J.M. (2015) Preventing and Treating Foot Complications Associated with Diabetes Mellitus. Nature Reviews Endocrinology, 11, 606-616. [Google Scholar] [CrossRef] [PubMed]
[4] Kerr, M., Rayman, G. and Jeffcoate, W.J. (2014) Cost of Diabetic Foot Disease to the National Health Service in England. Diabetic Medicine, 31, 1498-1504. [Google Scholar] [CrossRef] [PubMed]
[5] Armstrong, D.G., Tan, T., Boulton, A.J.M. and Bus, S.A. (2023) Diabetic Foot Ulcers: A Review. JAMA, 330, 62-75. [Google Scholar] [CrossRef] [PubMed]
[6] Dissemond, J., Bültemann, A., Gerber, V., Jäger, B., Kröger, K. and Münter, C. (2017) Diagnosis and Treatment of Chronic Wounds: Current Standards of Germany’s Initiative for Chronic Wounds e. V. Journal of Wound Care, 26, 727-732. [Google Scholar] [CrossRef] [PubMed]
[7] Zheng, S., Wan, X., Kambey, P.A., Luo, Y., Hu, X., Liu, Y., et al. (2023) Therapeutic Role of Growth Factors in Treating Diabetic Wound. World Journal of Diabetes, 14, 364-395. [Google Scholar] [CrossRef] [PubMed]
[8] Dewanjee, S., Das, S., Das, A.K., Bhattacharjee, N., Dihingia, A., Dua, T.K., et al. (2018) Molecular Mechanism of Diabetic Neuropathy and Its Pharmacotherapeutic Targets. European Journal of Pharmacology, 833, 472-523. [Google Scholar] [CrossRef] [PubMed]
[9] Radzieta, M., Sadeghpour-Heravi, F., Peters, T.J., Hu, H., Vickery, K., Jeffries, T., et al. (2021) A Multiomics Approach to Identify Host-Microbe Alterations Associated with Infection Severity in Diabetic Foot Infections: A Pilot Study. npj Biofilms and Microbiomes, 7, Article No. 29. [Google Scholar] [CrossRef] [PubMed]
[10] Sindrilaru, A. and Scharffetter-Kochanek, K. (2013) Disclosure of the Culprits: Macrophages—Versatile Regulators of Wound Healing. Advances in Wound Care, 2, 357-368. [Google Scholar] [CrossRef] [PubMed]
[11] Zubair, M. and Ahmad, J. (2019) Role of Growth Factors and Cytokines in Diabetic Foot Ulcer Healing: A Detailed Review. Reviews in Endocrine and Metabolic Disorders, 20, 207-217. [Google Scholar] [CrossRef] [PubMed]
[12] Park, K.H., Han, S.H., Hong, J.P., Han, S., Lee, D., Kim, B.S., et al. (2018) Topical Epidermal Growth Factor Spray for the Treatment of Chronic Diabetic Foot Ulcers: A Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Research and Clinical Practice, 142, 335-344. [Google Scholar] [CrossRef] [PubMed]
[13] Gomez‐Villa, R., Aguilar‐Rebolledo, F., Lozano‐Platonoff, A., Teran‐Soto, J.M., Fabian‐Victoriano, M.R., Kresch‐Tronik, N.S., et al. (2014) Efficacy of Intralesional Recombinant Human Epidermal Growth Factor in Diabetic Foot Ulcers in Mexican Patients: A Randomized Double‐Blinded Controlled Trial. Wound Repair and Regeneration, 22, 497-503. [Google Scholar] [CrossRef] [PubMed]
[14] Oliveira, B.C., de Oliveira, B.G.R.B., Deutsch, G., Pessanha, F.S. and de Castilho, S.R. (2021) Effectiveness of a Synthetic Human Recombinant Epidermal Growth Factor in Diabetic Patients Wound Healing: Pilot, Double‐Blind, Randomized Clinical Controlled Trial. Wound Repair and Regeneration, 29, 920-926. [Google Scholar] [CrossRef] [PubMed]
[15] Gu, Y., Cui, S., Wang, Q., Liu, C., Jin, B., Guo, W., et al. (2019) A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia. Molecular Therapy, 27, 2158-2165. [Google Scholar] [CrossRef] [PubMed]
[16] Berry-Kilgour, C., Cabral, J. and Wise, L. (2021) Advancements in the Delivery of Growth Factors and Cytokines for the Treatment of Cutaneous Wound Indications. Advances in Wound Care, 10, 596-622. [Google Scholar] [CrossRef] [PubMed]
[17] Laiva, A.L., O’Brien, F.J. and Keogh, M.B. (2017) Innovations in Gene and Growth Factor Delivery Systems for Diabetic Wound Healing. Journal of Tissue Engineering and Regenerative Medicine, 12, e296-e312. [Google Scholar] [CrossRef] [PubMed]
[18] Gurunathan, S., Kang, M., Jeyaraj, M., Qasim, M. and Kim, J. (2019) Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. Cells, 8, Article 307. [Google Scholar] [CrossRef] [PubMed]
[19] Cosenza, S., Toupet, K., Maumus, M., Luz-Crawford, P., Blanc-Brude, O., Jorgensen, C., et al. (2018) Mesenchymal Stem Cells-Derived Exosomes Are More Immunosuppressive than Microparticles in Inflammatory Arthritis. Theranostics, 8, 1399-1410. [Google Scholar] [CrossRef] [PubMed]
[20] Liang, Z., Lin, S., Pan, N., Zhong, G., Qiu, Z., Kuang, S., et al. (2022) UCMSCs‐Derived Exosomal circHIPK3 Promotes Ulcer Wound Angiogenesis of Diabetes Mellitus via miR‐20b‐5p/Nrf2/VEGFA Axis. Diabetic Medicine, 40, e14968. [Google Scholar] [CrossRef] [PubMed]
[21] Guo, J., Yang, X., Chen, J., Wang, C., Sun, Y., Yan, C., et al. (2023) Exosomal miR-125b-5p Derived from Adipose-Derived Mesenchymal Stem Cells Enhance Diabetic Hindlimb Ischemia Repair via Targeting Alkaline Ceramidase 2. Journal of Nanobiotechnology, 21, Article No. 189. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, B., Pang, M., Song, Y., Wang, H., Qi, P., Bai, S., et al. (2022) Human Fetal Mesenchymal Stem Cells Secretome Promotes Scarless Diabetic Wound Healing through Heat‐Shock Protein Family. Bioengineering & Translational Medicine, 8, e10354. [Google Scholar] [CrossRef] [PubMed]
[23] Ouyang, L., Qiu, D., Fu, X., Wu, A., Yang, P., Yang, Z., et al. (2022) Overexpressing HPGDS in Adipose-Derived Mesenchymal Stem Cells Reduces Inflammatory State and Improves Wound Healing in Type 2 Diabetic Mice. Stem Cell Research & Therapy, 13, Article No. 395. [Google Scholar] [CrossRef] [PubMed]
[24] De Gregorio, C., Contador, D., Díaz, D., Cárcamo, C., Santapau, D., Lobos-Gonzalez, L., et al. (2020) Human Adipose-Derived Mesenchymal Stem Cell-Conditioned Medium Ameliorates Polyneuropathy and Foot Ulceration in Diabetic BKS db/db Mice. Stem Cell Research & Therapy, 11, Article No. 168. [Google Scholar] [CrossRef] [PubMed]
[25] Zhang, C., Huang, L., Wang, X., Zhou, X., Zhang, X., Li, L., et al. (2022) Topical and Intravenous Administration of Human Umbilical Cord Mesenchymal Stem Cells in Patients with Diabetic Foot Ulcer and Peripheral Arterial Disease: A Phase I Pilot Study with a 3-Year Follow-Up. Stem Cell Research & Therapy, 13, Article No. 451. [Google Scholar] [CrossRef] [PubMed]
[26] Tao, S., Yuan, T., Rui, B., Zhu, Z., Guo, S. and Zhang, C. (2017) Exosomes Derived from Human Platelet-Rich Plasma Prevent Apoptosis Induced by Glucocorticoid-Associated Endoplasmic Reticulum Stress in Rat Osteonecrosis of the Femoral Head via the AKT/Bad/Bcl-2 Signal Pathway. Theranostics, 7, 733-750. [Google Scholar] [CrossRef] [PubMed]
[27] Guo, S., Tao, S., Yin, W., Qi, X., Yuan, T. and Zhang, C. (2017) Exosomes Derived from Platelet-Rich Plasma Promote the Re-Epithelization of Chronic Cutaneous Wounds via Activation of YAP in a Diabetic Rat Model. Theranostics, 7, 81-96. [Google Scholar] [CrossRef] [PubMed]
[28] Chen, C., Wang, Q., Li, D., Qi, Z., Chen, Y. and Wang, S. (2023) MALAT1 Participates in the Role of Platelet-Rich Plasma Exosomes in Promoting Wound Healing of Diabetic Foot Ulcer. International Journal of Biological Macromolecules, 238, Article 124170. [Google Scholar] [CrossRef] [PubMed]
[29] Liu, X., Yang, Y., Li, Y., Niu, X., Zhao, B., Wang, Y., et al. (2017) Integration of Stem Cell-Derived Exosomes with in Situ Hydrogel Glue as a Promising Tissue Patch for Articular Cartilage Regeneration. Nanoscale, 9, 4430-4438. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, C., Wang, M., Xu, T., Zhang, X., Lin, C., Gao, W., et al. (2019) Engineering Bioactive Self-Healing Antibacterial Exosomes Hydrogel for Promoting Chronic Diabetic Wound Healing and Complete Skin Regeneration. Theranostics, 9, 65-76. [Google Scholar] [CrossRef] [PubMed]
[31] Shi, Q., Qian, Z., Liu, D., Sun, J., Wang, X., Liu, H., et al. (2017) GMSC-Derived Exosomes Combined with a Chitosan/Silk Hydrogel Sponge Accelerates Wound Healing in a Diabetic Rat Skin Defect Model. Frontiers in Physiology, 8, Article 904. [Google Scholar] [CrossRef] [PubMed]
[32] Yang, J., Chen, Z., Pan, D., Li, H. and Shen, J. (2020) Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes Combined Pluronic F127 Hydrogel Promote Chronic Diabetic Wound Healing and Complete Skin Regeneration. International Journal of Nanomedicine, 15, 5911-5926. [Google Scholar] [CrossRef] [PubMed]
[33] Lemos, D.R., McMurdo, M., Karaca, G., Wilflingseder, J., Leaf, I.A., Gupta, N., et al. (2018) Interleukin-1β Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis. Journal of the American Society of Nephrology, 29, 1690-1705. [Google Scholar] [CrossRef] [PubMed]
[34] Avila-Rodríguez, M., Meléndez-Martínez, D., Licona-Cassani, C., Aguilar-Yañez, J., Benavides, J. and Sánchez, M. (2020) Practical Context of Enzymatic Treatment for Wound Healing: A Secreted Protease Approach (Review). Biomedical Reports, 13, 3-14. [Google Scholar] [CrossRef] [PubMed]
[35] Zhang, W., Tang, W., Hu, S., Fu, X., Wu, H., Shen, W., et al. (2023) Effect of Matrix Metalloproteinases on the Healing of Diabetic Foot Ulcer: A Systematic Review. Journal of Tissue Viability, 32, 51-58. [Google Scholar] [CrossRef] [PubMed]
[36] Li, G., Zou, X., Zhu, Y., Zhang, J., Zhou, L., Wang, D., et al. (2017) Expression and Influence of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers. The International Journal of Lower Extremity Wounds, 16, 6-13. [Google Scholar] [CrossRef] [PubMed]
[37] Nguyen, T.T., Ding, D., Wolter, W.R., Pérez, R.L., Champion, M.M., Mahasenan, K.V., et al. (2018) Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing. Journal of Medicinal Chemistry, 61, 8825-8837. [Google Scholar] [CrossRef] [PubMed]
[38] Ilizarov, G.A. (1989) The Tension-Stress Effect on the Genesis and Growth of Tissues: Part II. The Influence of the Rate and Frequency of Distraction. Clinical Orthopaedics and Related Research, 239, 263-285. [Google Scholar] [CrossRef
[39] Yang, Y., Li, Y., Pan, Q., Bai, S., Wang, H., Pan, X., et al. (2022) Tibial Cortex Transverse Transport Accelerates Wound Healing via Enhanced Angiogenesis and Immunomodulation. Bone & Joint Research, 11, 189-199. [Google Scholar] [CrossRef] [PubMed]
[40] Wen, R., Cheng, X., Cao, H., Zhang, L., Luo, F. and Shang, W. (2023) Transverse Tibial Bone Transfer in the Treatment of Diabetes Foot Ulcer: A Pilot Study. Diabetes, Metabolic Syndrome and Obesity, 16, 2005-2012. [Google Scholar] [CrossRef] [PubMed]
[41] Fan, Z., Yu, Z., Zheng, J., Yu, B. and Liu, D. (2020) Tibial Cortex Transverse Distraction in Treating Diabetic Foot Ulcers: What Are We Concerned About? Journal of International Medical Research, 48. [Google Scholar] [CrossRef] [PubMed]
[42] Albanna, M., Binder, K.W., Murphy, S.V., Kim, J., Qasem, S.A., Zhao, W., et al. (2019) In situ Bioprinting of Autologous Skin Cells Accelerates Wound Healing of Extensive Excisional Full-Thickness Wounds. Scientific Reports, 9, Article No. 1856. [Google Scholar] [CrossRef] [PubMed]
[43] Sharma, D., Ross, D., Wang, G., Jia, W., Kirkpatrick, S.J. and Zhao, F. (2019) Upgrading Prevascularization in Tissue Engineering: A Review of Strategies for Promoting Highly Organized Microvascular Network Formation. Acta Biomaterialia, 95, 112-130. [Google Scholar] [CrossRef] [PubMed]
[44] Qin, M., Guan, X., Zhang, Y., Shen, B., Liu, F., Zhang, Q., et al. (2018) Evaluation of ex Vivo Produced Endothelial Progenitor Cells for Autologous Transplantation in Primates. Stem Cell Research & Therapy, 9, Article No. 14. [Google Scholar] [CrossRef] [PubMed]